At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 13 enrolled
Drug / intervention
Phentermine +1 moredrug
Likely dose
Phentermine 37.5 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Quantification of Ingestive Behavior
In Brief
A Phase 4 clinical trial evaluating Phentermine and placebo for Obesity. Completed, enrolled 13 participants across 1 site.
Detailed Summary
The goal of this study is to determine whether one week of phentermine compared to placebo administration results in changes in food intake during a laboratory meal.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity
CountriesUnited States
CollaboratorsAstraZeneca
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2012
First PostedJun 2013
Primary CompletionJun 2014
TodayJul 2026
First PostedJun 26, 2013
Enrollment StartJul 1, 2012
Primary CompletionJun 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 13.0 years ago
Interventions
Phenterminedrug
After 7 days of phentermine 37.5 mg administration, food intake should be less than after 14 days of placebo.
placebodrug
Food intake as measured by a laboratory study should be greater after 7 days of placebo administration compared to seven days of phentermine administration.